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Abstract
IFN-a exerts multiple effects leading to immune protection against pathogens and cancer as well to autoimmune reactions
by acting on monocytes and dendritic cells. We analyzed the versatility of human monocytes conditioned by IFN-a towards
dendritic cell differentiation (IFN-DC) in shaping the autologous T-helper response. Priming of naı ¨ve CD4 T cells with
autologous IFN-DC in the presence of either SEA or anti-CD3, resulted, in addition to a prominent expansion of CXCR3+ IFN-
c-producing CD4 Th1 cells, in the emergence of two distinct subsets of IL-17-producing CD4 T cells: i) a predominant Th17
population selectively producing IL-17 and expressing CCR6; ii) a minor Th1/Th17 population, producing both IL-17 and IFN-
c. After phagocytosis of apoptotic cells, IFN-DC induced Th17 cell expansion and IL-17 release. Notably, the use of
neutralizing antibodies revealed that IL-23 was an essential cytokine in mediating Th17 cell development by IFN-DC. The
demonstration of the IFN-DC-induced expansion of both Th1 and Th17 cell populations reveals the intrinsic plasticity of
these DC in orienting the immune response and provides a mechanistic link between IFN-a and the onset of autoimmune
phenomena, which have been correlated with both IL-17 production and exposure to IFN-a.
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Introduction
IFN-a has been recently recognized as an important factor in
linking innate and adaptive immunity. In fact, through its rapid
secretion by specialized cells, such as plasmacytoid DC (pDC), and
concomitant capability to act on cells of innate and acquired
immunity [1,2], IFN-a promotes the induction of immune
responses, including auto-reactive responses. In fact, IFN-a has
beenconsidered as the driving factor in several human autoimmune
diseases such as Systemic Lupus Erythematosus (SLE) [3], myositis,
Sjogren’s syndrome and the initial phase of psoriasis [1].
IFN-a can contribute to the breaking of tolerance and to the
induction/expansion of auto-reactive T and B cells through direct
effects on these cells or by modulating immune functions through
the induction of DC costimulatory molecules and soluble factors
[1,4]. Interestingly, the association between an increased produc-
tion and or bioavailability of IFN-a and alterations in DC
homeostasis has been indicated in various human inflammatory
and autoimmune diseases. Of note, the Toll Like Receptor (TLR)-
dependent production of IFN-a by pDC may play a central role in
the pathogenesis of SLE [1,3] and psoriasis [5] by inducing the
differentiation of monocytes into highly activated myeloid DC.
The pathogenetic role of IFN-a in autoimmune disorders has
been traditionally attributed to its ability to polarize T-helper cells
toward the Th1 type of immune response and to induce the
generation/activation of effector immune cells [6]. However, the
discovery of IL-23 and IL-17 and the recognition of the new IL-
23/Th17 axis in the pathogenesis of a variety of inflammatory and
autoimmune diseases [7,8] have led to reconsider the role played
by cytokines other than IL-12, such as IFN-c, TGF-b, IL-6, IL-1b,
that are mainly produced by activated accessory cells and APC,
particularly DC. In this regard, however, the possible role of IFN-
a and DC in the induction of a Th17 CD4+ T cell response has
not yet been investigated.
We as well as others [2, and references therein] have demon-
strated that IFN-a induces the rapid differentiation of monocytes
into highly active DC (IFN-DC), capable of promoting Th1 type
immune responses through the expansion of CD4 and CD8 T cells
producing large quantities of IFN-c [9,10]. Further studies
suggested that cytokines belonging to the IL-12 cytokine family
(IL-23 and IL-27), could play a role in the Th1-promoting activity
of IFN-DC [10].
In this study, we have investigated the interaction between IFN-
DC and autologous naı ¨ve CD4 T cells. The characterization of the
cytokine milieu produced by IFN-DC revealed the release of
soluble factors known to promote Th17 differentiation. Consis-
tently, IFN-DC induced a clear-cut Th17 response and IL-17
production. Since Th17 lymphocytes have been implicated in the
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8pathogenesis of autoimmune disorders, these findings are instru-
mental in understanding how IFN-a, by shaping DC functions
including IL-23 release, can induce autoimmunity, thus leading to
a more comprehensive vision of the role of this cytokine in the
regulation of the immune response under both physiological and
pathological conditions.
Results
IFN-a-conditioned DC and induction of a Th1 type
response in the presence of SEA
In this study, two experimental systems were used in which
human naı ¨ve CD4 T cells purified from peripheral blood were co-
cultured with autologous IFN-DC or IL-4-DC and stimulated or
not with either the superantigen SEA Vbeta specific [11], which
activates a wide repertoire of T-cell receptors beta variable chains
(TCRV beta) with subsequent massive proliferation of CD4 T
cells, or anti-CD3-coated beads.
We preliminary evaluated the ensemble of cytokines accumu-
lating in the supernatant from DC cultures. The analysis of IFN-
DC cytokine milieu showed the presence, in addition to IL-12 and
IL-23 as previously reported [10], of high levels of TNF-a and IL-
6, together with lower levels of IL-1b (Fig. 1A). Significantly lower
or virtually undetectable levels of these cytokines were secreted by
IL-4-DC (Fig. 1A).
We then determined the profile and amount of cytokines
released in the supernatant of co-cultures stimulated or not with
SEA. As shown in Fig. 1B, in the absence of SEA the naı ¨ve CD4 T
cells secreted significantly higher levels of IFN-c when co-cultured
with autologous IFN-DC as compared toIL-4-DC. Stimulation
with SEA resulted in a substantial increase in the production of
IFN-c in the co-cultures of naı ¨ve CD4 T cells with either IFN-DC
or IL-4-DC. However, stimulation in the presence of IFN-DC
induced the release of much greater amounts of this cytokine.
Considerable amounts of IL-13 were released by the naı ¨ve CD4 T
cells co-cultured with IL-4-DC, whereas very low levels of this
cytokine were secreted by the naı ¨ve CD4 T cells co-cultured with
IFN-DC in the presence of the superantigen. Notably, significantly
higher levels of IL-23 were secreted by IFN-DC as compared to
IL-4-DC upon co-cultivation with autologous naı ¨ve CD4 T cells
Figure 1. Cytokine production by IFN-DC and IL-4-DC and induction of a Th1 type response in naı ¨ve CD4 T cells stimulated with
SEA in the presence of autologous DC. A) Cytokine production by IFN-DC and IL-4-DC. The amounts of the indicated cytokines were determined
by ELISA in the DC culture supernatants, as described in Materials and Methods, after three days (IFN-DC) or five days of differentiation (IL-4-DC). The
values represent the mean +/2 SD of five independent experiments. Statistical analysis was performed by Mann-Whitney test. * p,0.05. B) Cytokine
production in the supernatants of cultures of CD4 T cells stimulated with SEA in the presence of autologous IFN-DC or IL-4-DC. After six days of co-
cultures, the cytokine production was analyzed by ELISA as described in Materials and Methods. The values represent the mean +/2 SD of five
independent experiments. Statistical analysis was performed by Mann-Whitney test. * p,0.05. C) Representative dot plot analysis of intracellular
staining for IFN-c and IL-4 in CD4 T cells primed with SEA in the presence of autologous DC. Naı ¨ve CD4 T cells were stimulated with SEA in the
presence of autologous DC. At day 6 of co-culture, IFN-c or IL-4 production at single cell level was analyzed, after activation with PMA/ionomycin in
the presence of brefeldin-A as described in Materials and Methods, by intracellular cytokine staining. The analysis was performed on electronically
gated CD4+ T cells. D) FACS analysis of the co-expression of CD212 and CD25 or CXCR3 and CD25 on CD4 T cells co-cultured with autologous DC for
six days in the absence or presence of SEA. Each bar represents the percentage of double-positive CD4 T cells. Panels C and D show the results of one
representative experiment out of three.
doi:10.1371/journal.pone.0017364.g001
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CD4 T cell population after restimulation with PMA/ionomycin,
confirmed the explicit attitude of IFN-DC to strongly favor the
development of IFN-c-producing T cells (Fig. 1C). Likewise, the
analysis of the co-expression of the surface markers CXCR3 or
CD212 (IL-12Rb1chain) with the activation marker CD25
confirmed that IFN-DC efficiently expanded bona fide Th1 cells
(Fig. 1D).
Of note, IFN-DC were superior with respect to IL-4-DC in
inducing the expression of CD154 (CD40L), a marker of activated
CD4 T cells. At both intermediate and high SEA concentrations, a
higher percentage of CD154+ T cells was detected when the naı ¨ve
CD4 T cells were co-cultured with autologous IFN-DC as
compared to IL-4-DC (Fig. 2A), and CD154 membrane ex-
pression was far more intense in the co-cultures with IFN-DC as
compared to those with IL-4-DC, in the presence of either SEA or
anti-CD3 (Fig. 2B). Replacement of SEA with anti-CD3 coated
beads for naı ¨ve CD4 T cell activation resulted in a further increase
in CD154 expression exclusively on CD4 T cells co-cultured with
IL-4-DC, suggesting that IFN-DC provide per se an optimal co-
stimulation for efficient priming of CD4 T cells and maximal
CD154 expression (Fig. 2B).
IFN-a-conditioned DC produce a Th17 phenotype-
promoting cytokine environment
Notably, the profile of IFN-DC cytokine production was
strongly suggestive of a Th17 phenotype-promoting milieu
(Fig. 1A), as IL-1b, IL-6, and TNF-a, together with IL-23, have
been found to induce and sustain Th17 development [12,13]. In
the light of the particular efficiency of IFN-DC in inducing high
levels of CD154 in CD4 T cells (Fig. 2A and B) that are known to
reciprocally activate DC through CD40-CD154 interaction, we
then analyzed the cytokine production during the co-culture of
naı ¨ve CD4 T cells with autologous DC in the absence or in the
presence of either SEA or anti-CD3 coated beads, especially
focusing on IL-6 and IL-1b, which are known to play a key role in
Th17 development [13]. As shown in Fig. 3, considerable levels of
IL-6 (upper panel) and IL-1b (lower panel) were found in the co-
cultures of IFN-DC with naı ¨ve CD4 T cells in the absence of any
stimulus, and a similar increase was induced upon stimulation with
SEA or anti-CD3. In contrast, very low levels of IL-6 were
secreted in the co-cultures of IL-4-DC with naı ¨ve CD4 T cells in
the absence of stimuli, where IL-1b was virtually undetectable. An
increase of IL-6 secretion in the co-cultures of naı ¨ve CD4 T cells
with IL-4-DC occurred substantially in the presence of SEA and,
at a lower extent, of anti-CD3, whereas IL-1b secretion was
revealed only upon stimulation with SEA. Large amounts of TNF-
a, ranging from 1,159 pg +/2 306 to 1,592 +/2 254 (mean +/2
SD values), were invariably present in all culture conditions and
with both types of DC, while TGF-b was in any case undetectable
(data not shown).
IFN-DC-driven induction of Th17 CD4 T cells
In the light of the cytokine milieu produced by IFN-DC, we
evaluated whether these APC could favor the emergence of Th17
CD4 lymphocytes. In this set of experiments, anti-CD3-coated
beads were used to stimulate the naı ¨ve CD4 T cells in the co-
cultures with autologous DC, to obtain a higher percentage of
responding CD4 T cells and amplify the phenomenon. Remark-
ably, the FACS analysis demonstrated the concomitant expression
of CCR4 and CCR6 (Fig. 4), that is assumed to identify the Th17
CD4 subset [12,13], on a fraction of CD4 T cells primed in the
presence of autologous IFN-DC.
We have then assessed by CLSM analysis the expression of the
transcriptional factors T-bet and RoR-ct, specific for the Th1 and
Th17 subsets, respectively. The majority of CD4 T cells activated
in the presence of autologous DC selectively expressed T-bet,
Figure 2. IFN-DC are superior with respect to IL-4-DC in
inducing the expression of CD154 (CD40L). A) CD154 expression
by naı ¨ve CD4 T cells following isolation (CTR) and after activation with
different concentrations of SEA (1, 10, or 20 mg/ml) in the presence of
autologous DC (1:4 ratio) for 6 days. Each bar represents the mean
percentage +/2 SD of CD4 T cells expressing CD154, as derived from
three independent experiments. Statistical analysis was performed by
Mann-Whitney test. * p,0.05. B) Representative dot plot analysis of
CD154 expression by CD4 T cells activated with either SEA or anti-CD3
in the presence of autologous DC for 6 days. The two analyses were
performed on electronically gated CD4+ T cells.
doi:10.1371/journal.pone.0017364.g002
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B). Consistently with the results indicating the IFN-DC-induced
expansion of Th17 cells, the percentage of CD4 T cells expressing
RoR-ct was higher in the cultures stimulated with anti-CD3-
coated beads in the presence of autologous IFN-DC (mean
9.76SD 1.8%) than in the co-cultures with IL-4-DC (mean
2.56SD 2.4%) (Fig. 5A, B). The co-expression of T-bet and RoR-
ct was detected in about 1% of CD4 T cells expanded by anti-
CD3-coated beads and IFN-DC, whereas it was virtually absent in
the CD4 T cell-IL-4-DC co-cultures (Fig. 5B).
The production of IL-17 was evaluated after six days of CD4 T
cell-DC co-culture in the presence of SEA or anti-CD3-coated
beads by ELISA (Fig. 5C, top and middle panel) and by
intracellular IL-17 staining to detect and quantify IL-17-producing
cells by FACS analysis (Fig. 5D). The ELISA results clearly
demonstrated the release of significantly higher amounts of IL-17
upon SEA or anti-CD3 stimulation of CD4 T cells in the presence
of autologous IFN-DC, as compared to the co-culture with IL-4-
DC. Considerable levels of IL-22, cytokine also associated to the
Th17 phenotype, were secreted after stimulation of naive CD4 T
cells with anti-CD3-coated beads in the presence of either type of
autologous DC (Fig. 5C, bottom panel).
Intracellular staining for the detection of IFN-c and IL-17 after
restimulation of the expanded CD4 T cells with PMA/ionomycin,
confirmed not only the efficiency of IFN-DC in promoting the
expansion of IFN-c-producing Th1 cells, but also their capability
to induce the development of IL-17-producing T cells (Fig. 5D). A
small but clearly detectable fraction of cells producing both IL-17
and IFN-c was identified in the cultures of CD4 T cells stimulated
with SEA or anti-CD3-coated beads in the presence of IFN-DC
(Fig. 5D). We could not detect any expansion of Th17 cells nor IL-
17 production when naı ¨ve CD4 T cells were activated with anti-
CD3 plus anti-CD28 in the presence of IL-2 and IL-23 (data not
shown), ruling out the possibility of the outgrowth of contaminat-
ing memory Th17 cells.
Role of IFN-DC-secreted cytokines in the induction of
Th17 cell development
We then asked which IFN-DC cytokines were required for IL-
17 induction in naı ¨ve CD4 T cells. As expected, the antibody
blockade of an ensemble of cytokines (i.e. IL-1b, IL-6, TNF-a, and
IL-12/IL-23) markedly inhibited IL-17 production (Fig. 6A),
whereas neutralization of single cytokines did not significantly
Figure 3. Release of IL-6 and IL-1b after co-culture of naı ¨ve CD4
T cells with autologous DC. The amount of IL-6 and IL-1b released in
the co-cultures of naı ¨ve CD4 T cells with autologous DC, with or without
activation with SEA or anti-CD3 coated beads, was determined by ELISA
after 6 days of co-culture. The values represent the mean +/2 SD of four
independent experiments. Statistical analysis was performed by Mann-
Whitney test. * p,0.05.
doi:10.1371/journal.pone.0017364.g003
Figure 4. Estimation of the emergence of Th17 cells by analysis
of surrogate cell marker expression. Dot plot analysis of the
expression of CCR6 and CCR4 on CD4 T cells after a 6-day stimulation
with SEA or anti-CD3 coated beads in the presence of autologous DC.
The results of one representative experiment out of five independently
performed are shown. In all cases, the analysis was performed on
electronically gated CD4+ T cells.
doi:10.1371/journal.pone.0017364.g004
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of IFN-DC. A) CLSM analysis (central optical sections) was performed on CD4 T cells activated by anti-CD3-coated beads in the presence of
autologous DC for six days to evaluate the expression of the transcription factors T-bet and RoR-ct (pseudo-color grey). Cell nuclei were stained with
DAPI (blue). Insets represent background labelling of isotype control antibodies. One representative experiment out of three independently
performed is reported. B) Co-expression of the transcription factors T-bet (red) and RoR-ct (green) in CD4 T cells activated with anti-CD3-coated
beads in the presence of autologous DC for six days, as observed in a representative experiment out of three. Cell nuclei were stained with DAPI
(blue). One representative experiment out of three independently performed is reported. C) Production of IL-17 and IL-22 in the culture supernatants
of CD4 T cells stimulated in the presence of autologous DC. Naı ¨ve CD4 T cells were stimulated with SEA or anti-CD3 in the presence of autologous DC
for six days. The values represent the mean +/2 SD of four independent experiments. Statistical analysis was performed by Mann-Whitney test.
* p,0.05. D) Production of IL-17 by a fraction of CD4 T cells, as demonstrated by intracellular cytokine staining. The dot plot analysis, representative
of one out of five experiments, shows the intracellular IFN-c and L-17 expression by CD4 T cells primed with SEA or anti-CD3 in the presence of
autologous DC for six days. Upon activation with PMA/ionomycin in the presence of brefeldin-A for 5 hours, as described in Materials and Methods,
cells were stained for the CD4 antigen, permeabilized and stained for intracellular IFN-c and IL-17. Analysis was performed on electronically gated
CD4+ T cells.
doi:10.1371/journal.pone.0017364.g005
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neutralizing antibodies against the IL-23p19 and the IL-12/IL-
23p40 consistently and markedly inhibited IL-17 production in the
co-cultures of naı ¨ve CD4 T cells with IFN-DC (Fig. 6A). The
combination of anti-p19 and anti-p40 antibodies was used to
obtain the highest possible neutralization of IL-23 as, in our
experimental setting, the addition of the anti-p19 antibody alone
reproducibly resulted in only a limited neutralization of IL-23 and
a slight inhibition of IL-17 production (data not shown). In
contrast, the addition of both anti-p19 and anti-p40 antibodies
resulted not only in a virtually complete disappearance of IL-23
(Fig. 6B, upper graph), but also in a sharp reduction of IFN-c
production in the co-cultures of naı ¨ve CD4 T cells with autologous
IFN-DC (Fig. 6B, lower graph). No significant increase in the
inhibition of IL-17 production was observed when anti-IL-1b,
anti-IL-6 or anti-TNF-a neutralizing antibodies were added
together with the anti-p40 antibodies to the anti-CD3-activated
naı ¨ve CD4 T cell-IFN-DC co-cultures (Fig. 6A). Overall, these
results together with the observation that much higher levels of IL-
23 as compared to IL-12 were reproducibly detected in those co-
cultures (data not shown), strongly indicate IL-23 as an essential
cytokine in mediating human Th17 cell development by IFN-DC.
IFN-DC phagocytosis of apoptotic cells induces the
production of Th17 inducing cytokines and IFN-c
A recent study demonstrated that in mouse models the
phagocytosis of apoptotic cells by DC in the presence of
infection-induced signals promotes Th17 cell differentiation [14].
To investigate whether apoptotic cell-loaded IFN-DC could
promote the expansion of IL-17-secreting cells, we cultivated naı ¨ve
CD4 T cells with autologous DC which had phagocytosed
apoptotic melanoma (Me501) or cervical cancer (CaSki) cells.
Interestingly, a notable increase in the percentage of CD154+ cells
was induced by the co-cultivation of naı ¨ve CD4 T cells with
apoptotic cell-loaded IFN-DC (Fig. 7A). As shown in Fig. 7B, the
uptake of apoptotic tumor cells induced a massive production of
IL-6 in both IFN-DC and IL-4-DC, while the production of IL-23
was selectively induced in IFN-DC. On the contrary, only
irrelevant levels of IL-1b could be detected in all the conditions
tested. Upon culture of naı ¨ve CD4 T cells with autologous DC
loaded with apoptotic cells, high levels of IL-6 were found in the
supernatants of all the different DC-CD4 T cells co-cultures,
whereas IL-1b and IL-23 were produced mainly in the co-cultures
of CD4 T cells with apoptotic cell-loaded IFN-DC (Fig. 7C). High
levels of TNF-a were present in all culture conditions, while TGF-
b was in all cases undetectable (data not shown).
Notably, the expansion of CCR6/CCR4 double positive cells
clearly induced by stimulation with apoptotic cell-loaded IFN-DC
(Fig. 7D), correlated with the levels of IL-17 detected in the
corresponding culture supernatants (Fig. 7E), indicating the
capability of IFN-DC which had phagocytosed apoptotic tumor
cells to drive Th17 differentiation. Significantly higher levels of
IFN-c were induced following stimulation of naive CD4 T cells
with apoptotic cell-loaded IFN-DC as compared to IL-4-DC
Figure 6. Inhibition of IL-17 production by selective cytokine
neutralization. A) Inhibition of IL-17 production by selected couples
or cocktail of cytokine blocking antibodies. Naı ¨ve CD4
+ T cells were
activated with anti-CD3 coated beads and autologous DC at a cell ratio
of 1:4 in the presence of the indicated couples of cytokine-neutralizing
antibodies, or of the respective control isotypes. The presence of IL-17
was analyzed in the supernatants of cell cultures after 6 days by ELISA.
The effect of the control isotypes couples on IL-17 production was not
significantly different from that of the control isotypes cocktail. The
values represent the mean +/2 SD of three independent experiments.
Statistical analysis was performed by Mann-Whitney test. * p,0.05. B)
Inhibition of IFN-c and IL-23 production by selective IL-23/IL-12
neutralization as compared to the inhibition obtained with the
complete neutralizing cocktail, including antibodies to the p40 subunit
of IL-12 and IL-23, p19 (IL-23), IL-1b, TNF-a and IL-6. Th values represent
the mean +/2 SD of three independent experiments. Statistical analysis
was performed by Mann-Whitney test. * p,0.05.
doi:10.1371/journal.pone.0017364.g006
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PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e17364Figure 7. Induction of Th17 response by DC loaded with apoptotic cells. A) Representative dot plot analysis (one out of three) of CD154
induction in CD4 T cells after 6 days of culture with autologous IFN-DC or IL4-DC fed with apoptotic cells. The upper dot plots show CD154 expression
in purified naı ¨ve CD4 T cells prior to use. CTR dot plots show the percentage of CD154 expression by CD4 T cells cultivated in the presence of
autologous DC which had not phagocytosed apoptotic tumor cells. Analysis was performed on electronically gated CD4+ T cells. The percentage of
early and late apoptotic tumor cells was evaluated by Annexin-V/propidium iodide staining. B) ELISA detection of IL-1b, IL-6 and IL-23 release by DC
upon phagocytosis of apoptotic tumor cell lines. Analysis was performed after 18 hours from tumor cell uptake. The values represent the mean +/2
SD of three independent experiments. C) ELISA detection of IL-1b, IL-6 and IL-23 in supernatants from co-culture of CD4 T cells with autologous DC
which had phagocytosed apoptotic cells. After three days of co-culture, CD4 T cells were restimulated overnight with anti-CD3 coated beads. At day
four the supernatant was collected for cytokine detection. All data are expressed as the mean +/2 SD of three independent experiments. Statistical
analysis was performed by Mann-Whitney test. * p,0.05. D) Dot plot analysis of CCR6/CCR4 expression by CD4 T cells after six days of stimulation in
the presence of DC fed with apoptotic tumor cells or autologous PBL. The results of one representative experiment out of three are shown. In all case,
the analysis was performed on electronically gated CD4+ T cells. E) Evaluation of IL-22, IL-17 and IFN-c production at day 4, after overnight
restimulation of CD4 T cells with anti-CD3 coated beads. All data are representative of one out of three independent experiments performed with
cells derived from different donors. The values represent the mean +/2 SD of three independent experiments. Statistical analysis was performed by
Mann-Whitney test. * p,0.05.
doi:10.1371/journal.pone.0017364.g007
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detected in all conditions.
An expansion of CCR6/CCR4 double positive cells was found
to occur also upon stimulation of naive CD4 T cells with IFN-DC
fed with apoptotic autologous PBLs (Fig. 7D), arguing against the
possibility that the Th17-inducing capability of apoptotic cell-
loaded IFN-DC was dependent on tumor cell-specific factors.
Discussion
Here we have shown that IFN-a-conditioned DC can act as
effective APC in driving the development of Th17 cells from
autologous naı ¨ve CD4 T cells. In fact, the priming of naı ¨ve CD4 T
cells with autologous IFN-DC in the presence of either SEA or
anti-CD3, resulted, in addition to a prominent expansion of
CXCR3+ IFN-c-producing CD4 Th1 cells, in the emergence of
two distinct subsets of IL-17-producing CD4 T cells: i) a
predominant Th17 population selectively producing IL-17 and
expressing CCR6; ii) a minor Th1/Th17 population, producing
both IL-17 and IFN-c (Fig. 5D).
The exact requirements of individual cytokines or their
combination for human Th17 differentiation are still controversial
[7]. Recent reports have indicated an important role of IL-1b, IL-
6 and IL-23 in human Th17 differentiation [7,8,12–17].
Notwithstanding, human IL-17A-producing cells have been
recently demonstrated to originate from CD161+ CD4+ T-cell
precursors upon activation in the presence of IL-1b plus IL-23.
The essential role of IL-23 either in inducing IL-17 production by
human T cells [18] or in promoting the maintenance rather than
the priming of the IL-17-secreting cell population has been also
demonstrated [19]. However, the in vivo cytokine requirements for
human Th17 differentiation are still matter of investigation,
particularly under the physiological setting of naı ¨ve CD4 T cells
encountering antigen-presenting DC in the lymph nodes. Recent
reports demonstrated that human DC differentiated in vitro from
monocytes and activated through TLR [20] or inflammatory
cytokines [21] were more efficient APC as compared to monocytes
in inducing the expansion of IL-17-secreting cells upon stimulation
of either allogeneic [20] or autologous T cells [21].
Here, we demonstrate, for the first time, that IFN-a-conditioned
monocyte-derived DC act as highly efficient APC in inducing
autologous IL-17-secreting Th17 cells, and that this effect is
mediated by IL-23 and IL-12, as clearly indicated by the results of
the neutralization experiments (Fig. 6). Our observation that much
higher levels of IL-23 as compared to IL-12 were reproducibly
detected in the cultures of naı ¨ve CD4 T cells stimulated with anti-
CD3-coated beads in the presence of IFN-DC (data not shown),
strongly support the predominant role of IL-23 in mediating
human Th17 cell development by IFN-DC. Although our results
argue against an essential role of IL-1b in the IFN-DC-induced
expansion of IL-17-secreting cells, we cannot rule out that the low
basal levels of IL-1b secreted by IFN-DC are indeed playing an
important role in the priming of naı ¨ve CD4 T cells towards the IL-
17-secreting phenotype, as also suggested by a recent report [20].
Notably, the IFN-DC capability to promote a Th17 response may
also reside on their particular efficiency in inducing the expression
of the CD40 ligand CD154 (Fig. 2 and 7A), as CD40-CD40L
cross-talk has been recently reported to play a role in the
establishment of the Th17 response [22].
Interestingly, at variance with previous reports [23,24], the
high levels of IFN-c secreted upon stimulation of naı ¨ve CD4 T
cells with IFN-DC did not appear to abrogate the capability of
IFN-DC to induce the differentiation of Th17 cells from naı ¨ve
CD4 T cell precursors. Two opposite effects of IFN-c on APC
have been recently identified: the inhibition of the capacity to
polarize the immune response towards the Th1 profile and the
induction of IL-1b and IL-23 production, resulting in the
expansion of memory Th17 cells [25]. The novel pathway of
A P C - m e d i a t e dTc e l ld i f f e r e n t i a tion indicated by our study is
fully consistent with the dynamic model proposed by Kryczek
and coworkers [25]. In particular, the ensemble of our data
unravel a new scenario in which IFN-a, cytokines produced early
in response to viral infections or other danger signals, can rapidly
induce a polyfunctional DC type, i.e. the in vivo counterpart of
IFN-DC, capable of secreting IL-12, IL-1b and IL-23 and
concomitantly inducing the emergence of Th1, Th17 and Th1/
Th17 CD4 T cells. The IFN-c produced by the differentiated
Th1 cells may trigger the further production of IL-23 by IFN-
DC, promoting the expansion of memory Th17 cells. This
scenario (Fig. 8) is consistent with the observation that the levels
of IL-23 strongly increase when IFN-DC are co-cultured with
activated CD4 T cells (Fig. 1B, 3B, and 7B), as a consequence of
IFN-c production induced by IFN-DC-secreted IL-12 and IL-23.
Of note, in our study the neutralization of IL-12 and IL-23
resulted in a sharp reduction of IFN-c secretion in the co-culture
of naı ¨ve CD4 T cells with autologous IFN-DC (Fig. 6). Taking
intoconsiderationthe rapid exhaustion of IL-12 that we observed
in the co-cultures of CD4 T cells with autologous IFN-DC (data
not shown), it can be envisaged that, in the above proposed
scenario, the IL-12 would act in the initial phase by priming the
Th1 response, whereas the IL-23 would contribute to the
maintenance of both the Th1 and the Th17 memory subsets,
in agreement with previous reports [26,27].
The capability of IFN-DC to expand both a Th1 and a Th17
population is consistent with the new concept that both these
subsets play a role in the pathogenesis of inflammatory and
autoimmune diseases. The IFN-DC-mediated induction of CD4 T
cells co-expressing IFN-c and IL-17, the Th1/Th17 cells, is also
interesting in the light of the evidence that in patients with certain
autoimmune diseases (e.g. Crohn disease, uveitis), a considerable
fraction of T cells secreting IL-17 in the tissue was described to
express both IFN-c and IL-17 [28,29].
Both IL-17 and IFN-a have been implicated in the pathogenesis
of some autoimmune and inflammatory diseases. SLE represents a
prototypic autoimmune disease characterized by a break of
tolerance to self molecules, for which the possible pathogenetic
role of IFN-a has been strongly emphasized [3]. Moreover, the
seminal work by Banchereau’s group demonstrated that the IFN-a
contained in the sera from SLE patients induces the differentiation
of circulating monocytes into APC strongly resembling IFN-DC
[30].
Rheumatoid arthritis (RA) [31], Crohn’s disease [32,33], and
psoriasis [34] are other autoimmune inflammatory conditions in
which an IFN-a/IL-23/IL-17 axis may be involved. Interestingly,
activated DC infiltration has been shown in Crohn’s samples [32]
with IL-23 mediating intestinal inflammation [33].
Our results clearly demonstrate that in an autologous human in
vitro setting IFN-a acts on monocytes inducing their differentiation
into APC capable of promoting the induction and expansion of
both Th1 and IL-17-secreting, i.e. Th17 and Th1/Th17, subsets
from naı ¨ve CD4 T cells.
IFN-a represents the cytokine exhibiting the longest record of
use in clinical oncology and many data support the concept that
the antitumor response observed in IFN-treated cancer patients is
mediated by an activation of immune cells, including T
lymphocytes [6] and DC [35]. Intriguingly, in melanoma patients,
a striking correlation between the clinical response and the
development of signs of autoimmune reactions has been
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immunity often accompany one another, strongly suggesting that
autoimmunity is a correlate of therapeutic benefit [37]. In the light
of all this and of the recent evidence that Th17 cells play a role in
immune-mediated control of tumors [38,39,40], our results may
provide a mechanistic interpretation for the observed coupling of
protective antitumor immunity with autoimmunity during IFN-a
therapy. In fact, in previous studies we demonstrated that IFN-DC
can effectively mediate the cross-priming of IFN-c-secreting CD8
T cells against exogenous antigens [10], including apoptotic cell-
derived antigens [41]. In the present study, we show that IFN-DC
can also prime a Th17 response upon uptake of apoptotic cell-
derived materials from tumor cells or autologous PBLs. Thus, we
can assume that IFN-DC developing in vivo under pathological
conditions or during IFN-a therapy can take-up apoptotic bodies
from tumor cells and self cells as well, and can prime both Th1 and
Th17 responses, thus leading to the expansion and activation of
effectors T cells reactive against tumor-associated and self
antigens.
The main research challenge in cancer immunotherapy is the
development of effective and selective antitumor response, limiting
immune attack to normal tissues. The understanding of how IFN-
DC can induce a Th17 cell response can open new perspectives for
the treatment of some autoimmune diseases and for the




Peripheral blood mononuclear cells utilized in this study derived
from buffy coats obtained from healthy blood donors, as
anonymously provided by the Immunohematology and Transfu-
sional Center of Policlinico Umberto I, University ‘‘La Sapienza’’,
Rome. Written informed consent for the use of buffy coats for
research purposes was obtained from blood donors by the
Transfusional Center and both the informed consent form and
procedure was approved by the Ethics Committee of Policlinico
Umberto I. Data related to human samples were all analyzed
anonymously.
Cell preparation
Peripheral blood mononuclear cells were purified by Ficoll
density gradient centrifugation (Biochrom AG). Monocytes were
isolated by immunomagnetic positive selection (MACS Cell
Isolation Kits; Miltenyi Biotec) and plated at the concentration
of 2610
6 cells/ml in RPMI medium (GIBCO BRL), supplement-
ed with 10% FBS, 500 U/ml GM-CSF (Peprotech) and either
250 U/ml IL-4 (R&D Systems) for 5 days or 10,000 U/ml IFN-
a2b (Intron A; Shering-Plough) for 3 days. Negatively selected
PBLs were used to isolate naı ¨ve CD4+ T cells by negative selection
using the Naı ¨ve CD4 T cell isolation kit II (Miltenyi Biotec). The
isolated naı ¨ve CD4+ T cells proved to be at least 95% pure.
Figure 8. Model on the induction of Th17 cell development by IFN-a-conditioned DC. Distinct cell types, such as monocytes, NK cells and
pDC can produce biologically relevant quantities of type I IFNs under different stimulation conditions, such as danger signals represented by a wide
array of inflammatory cytokines and molecules derived from viruses and bacteria. In particular, pDC are responsible for producing very high levels of
IFN-a in response to viral infections. Endogenous IFN-a production affects several immune functions and act by promoting DC differentiation from
circulating monocytes and DC activation. These IFN-a-conditioned DC, which may represent the in vivo counterpart of IFN-DC, produce a wide array
of inflammatory cytokines including IL-12, IL-1b and IL-23 which act on naı ¨ve CD4 T cells sustaining their differentiation into Th1 or Th17 cells. The
IFN-c produced at high levels by the Th1 cells enhances the APC production of IL-1b and IL-23, which, in turn, act on both Th1 and Th17 memory
cells, promoting their expansion. In this scenario, IL-12 would act in the initial phase by priming the Th1 response, whereas IL-23 would contribute to
the maintenance of both Th1 and Th17 memory cells.
doi:10.1371/journal.pone.0017364.g008
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Cytokine quantification was performed by commercial ELISA
kits for: IL-1b, IL-4, IL-6, IFN-c, TNF-a IL-12 (Endogen), IL-23
(Bender MedSystem), IL-13, IL-17, IL-22, TGF-b1 (R&D
Systems) according to manufacturer instruction.
CD4+ T cells activation
DC, obtained as described above, were washed and cultured
with autologous naı ¨ve CD4+ T cells (1:4 ratio) and 1 mg/ml SEA
(Staphylococcal enterotoxin A, Sigma-Aldrich) for 6 days at 37uC,
or anti-CD3 coated beads (T cell activation/Expansion Kit.
Miltenyi Biotech), using the manufacturer’s recommendations.
FACS analysis of surface markers and intracellular
cytokine expression
Cells were stained with a panel of fluorochrome-conjugated
mAbs (BD Bioscience, R&D Systems) specific for T cells (anti-
CD4, anti-CD25, anti-CXCR3, anti-CD212, anti-CCR6, anti-
CCR4, anti-CD154).
Cytokine staining was performed after 6 days of DC/naı ¨ve T
cells culture (1:4 ratio). Cells were stimulated for 5 h with PMA
(40 ng/ml) and ionomycin (500 ng/ml) (Sigma-Aldrich), in the
presence of Golgi Plug (1 mg/ml) (BD Pharmingen) for the final
4 h of culture at 37uC. Cells were fixed and permealized with BD
Cytofix/Cytoperm Plus (BD Biosciences Pharmingen) and incu-
bated at 4uC for 30-min with FITC-labeled anti IFN-c (BD
Pharmingen), PE-labelled anti IL-4 (BD Pharmingen), or PE-
labelled anti IL-17 (eBioscience), washed and analyzed on a
FACScalibur cytometer with CellQuest software (Becton Dick-
inson).
Confocal laser scanning microscopy (CLSM) analysis.
CD4 T cells were seeded on cover glasses coated with poly-L-
lysine (Sigma-Aldrich) Cells were fixed by paraformaldehyde
(PFA) 3% (30 min, 4uC), permeabilized by Triton X-100 (0.5%
10 min at room temperature, Sigma-Aldrich) and then stained at
37uC with phycoerythrin (PE) anti mouse T-Bet Ab (eBioscience)
and/or with rabbit polyclonal anti RoR-ct Abs (ABCAM),
followed by Alexa Fluor 488 conjugated goat anti rabbit Abs
(Molecular Probes). CLSM observations were performed with a
Leica TCS SP2 AOBS apparatus. Image acquisition and
processing were carried out using the Leica Confocal Software
(Leica Lasertechnik). At least 1000 cells were analyzed in each
field.
Neutralization Assay
DC were cultured with autologous naı ¨ve CD4+ T cells at a ratio
of 1:4 and anti-CD3 activation beads (Milteny Biotech), in the
presence of the following neutralizing antibodies: anti-IL-1b
(10 mg/ml), anti-IL-6 (10 mg/ml), anti-TNF-a (10 mg/ml)
(eBioscience), anti-IL-23p19 (10 mg/ml) (R&D Systems), anti-IL-
12p40 (10 mg/ml) (Abcam), or the respective isotypic controls Abs.
IL-17, IFN-c and IL-23 production was analyzed after 6 days by
ELISA (R&D Systems).
Induction of Th17 response by DC loaded with apoptotic
tumor cells
DC were loaded with apoptotic Me501 (melanoma) and CaSki
(cervical cancer) tumor cells prior to co-culture. Apoptosis of Caski
or Me501 cell lines was induced with UV-irradiation and
monitored by Annexin-V-FITC Apoptosis detection Kit from
PharMingen (Becton Dickinson Company, CA USA) and cultured
with DC at a DC-tumor ratio of 1:1 for 18 hours. Tumor-loaded
DC were then used to stimulate autologous T CD4 naı ¨ve cells at a
S:R ratio of 1:4. After 4 days of culture, the presence of IL-17-
producing T cells was monitored by ELISA after stimulation with
anti-CD3 coated beads (T cell activation kit, MiltenyiBiotec) for
additional 24 h.
Statistical analysis
All results are expressed as mean 6 SD, whereas the statistical
analysis was performed by Mann-Whitney test.
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